JP2024533426A5 - - Google Patents

Info

Publication number
JP2024533426A5
JP2024533426A5 JP2024515577A JP2024515577A JP2024533426A5 JP 2024533426 A5 JP2024533426 A5 JP 2024533426A5 JP 2024515577 A JP2024515577 A JP 2024515577A JP 2024515577 A JP2024515577 A JP 2024515577A JP 2024533426 A5 JP2024533426 A5 JP 2024533426A5
Authority
JP
Japan
Prior art keywords
compound according
ch2oc
inhibitor
substituted
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533426A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076360 external-priority patent/WO2023039600A1/en
Publication of JP2024533426A publication Critical patent/JP2024533426A/ja
Publication of JP2024533426A5 publication Critical patent/JP2024533426A5/ja
Pending legal-status Critical Current

Links

JP2024515577A 2021-09-13 2022-09-13 糖誘導体の薬物コンジュゲート及び老化細胞除去剤としてのその使用 Pending JP2024533426A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163243539P 2021-09-13 2021-09-13
US63/243,539 2021-09-13
PCT/US2022/076360 WO2023039600A1 (en) 2021-09-13 2022-09-13 Drug conjugates of sugar derivatives and uses thereof as senolytic agents

Publications (2)

Publication Number Publication Date
JP2024533426A JP2024533426A (ja) 2024-09-12
JP2024533426A5 true JP2024533426A5 (https=) 2025-09-22

Family

ID=85507744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515577A Pending JP2024533426A (ja) 2021-09-13 2022-09-13 糖誘導体の薬物コンジュゲート及び老化細胞除去剤としてのその使用

Country Status (7)

Country Link
US (3) US20230137021A1 (https=)
EP (1) EP4380575A4 (https=)
JP (1) JP2024533426A (https=)
CN (1) CN118475356A (https=)
AU (1) AU2022342245A1 (https=)
CA (1) CA3232213A1 (https=)
WO (1) WO2023039600A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023039292A2 (en) * 2021-09-13 2023-03-16 Rubedo Life Sciences, Inc. Novel sugar derivatives and uses thereof to prepare novel senolytic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2710322T3 (es) * 2012-08-28 2019-04-24 Univ Tuebingen Medizinische Fakultaet Trazadores de la senescencia
IL286427B2 (en) * 2014-01-28 2024-08-01 Mayo Found Medical Education & Res Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease
US20210180013A1 (en) * 2018-04-23 2021-06-17 Agex Therapeutics, Inc. Improved methods for inducing tissue regeneration and senolysis in mammalian cells
US11026963B2 (en) * 2018-07-11 2021-06-08 Rubedo Life Sciences, Inc. Senolytic compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2022533069A5 (https=)
JP2021531249A5 (https=)
CN101142198B (zh) 用于治疗疾病的异*唑坎布雷它斯丁衍生物
JP2022523786A5 (https=)
JP2018518537A5 (https=)
JP2021534124A5 (https=)
JP2009544602A5 (https=)
JP2008512490A5 (https=)
JP2007501862A5 (https=)
JP2009519243A5 (https=)
JP2006506425A5 (https=)
JP5149177B2 (ja) 増殖性疾患の治療のための、チューブリンポリマー化の１，２，３−トリアゾール系抑制剤
JP2020507589A5 (https=)
JP2018534286A5 (https=)
JP2010505865A5 (https=)
JP2008201787A5 (https=)
JP2020520926A5 (https=)
JP2021530513A5 (https=)
JP2024533426A5 (https=)
JP2018123122A5 (https=)
JP2014519507A5 (https=)
JP2022521955A5 (https=)
JP2020510660A5 (https=)
JP2002503714A5 (https=)
CA2600409A1 (en) Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds